Amneal Pharmaceuticals, Inc. - Class A Common Stock - Çeyreklik Finansal İstatistikler (NASDAQ:AMRX)

Financials

İşletme faaliyetlerinden elde edilen nakit 118.08 M7.41 M83.82 M118.45 M130.31 M-26.74 M 305.84 M Yatırım faaliyetlerinden elde edilen nakit -16.06 M-17.8 M-26.55 M-22.46 M-45.45 M-21.71 M -116.17 M Finansman faaliyetlerinden elde edilen nakit -61.2 M-39.17 M-41.69 M59.44 M-10.12 M-59.05 M -51.42 M Serbest nakit akışı 118.08 M7.41 M60.09 M98.74 M105.54 M-42.77 M 221.6 M

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.

AMRX

Financials

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Haberler

Is it a Good Idea to Invest in Amneal Pharmaceuticals Stock Now?

Why Amneal Pharmaceuticals (AMRX) is a Top Growth Stock for the Long-Term

3 Reasons Why Growth Investors Shouldn't Overlook Amneal (AMRX)

Should Value Investors Buy Amneal Pharmaceuticals (AMRX) Stock?

Teva’s CNS Portfolio Is Growing, But Valuation Is Stretched (NYSE:TEVA)

Amneal (AMRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)

Do Options Traders Know Something About Amneal Stock We Don't?

Amneal Pharma 1Ç 2026 hisse başı kazanç tahminini aştı

Amneal’in 750 milyon dolarlık Kashiv anlaşması biyobenzer liderliği yaratıyor

Is Amneal (AMRX) a Solid Growth Stock? 3 Reasons to Think "Yes"

Wall Street Analysts See a 34.77% Upside in Amneal (AMRX): Can the Stock Really Move This High?

Amneal Pharmaceuticals (AMRX) is a Top-Ranked Momentum Stock: Should You Buy?